Day: January 18, 2021

January 18, 2021AkzoNobel proposes to acquire Tikkurila for €31.25 per share, to create superior and sustainable value for all stakeholdersAkzo Nobel N.V. (AKZA; AKZOY) has today made a comprehensive non-binding proposal to acquire Tikkurila. The proposed combination of AkzoNobel and Tikkurila would create a strong platform for future growth, better able to serve customers with more innovative and sustainable solutions, building on a shared European heritage.The proposal includes an all-cash public offer for all issued and outstanding shares of Tikkurila at an offer price of €31.25 per share (“potential offer”) and total equity value of around €1.4 billion. This represents a premium of 113% to Tikkurila’s volume weighted average share price for the undisturbed three-month period ending December 17, 2020 and is 13% higher than the current...

Oslo, 18 January 2021 – DNO ASA, the Norwegian oil and gas operator, today announced net production of 95,100 barrels of oil equivalent per day (boepd) across its portfolio in 2020, notwithstanding the sharp decline in planned spending to preserve cash following the market turmoil triggered by the Covid-19 pandemic. Gross operated production from the Company’s flagship Tawke license in the Kurdistan region of Iraq, about evenly split between the Tawke and Peshkabir fields, averaged 110,300 barrels of oil per day (bopd) with 77,700 bopd net to DNO’s interest. Last year was the sixth consecutive year in which gross Tawke license production has averaged over 100,000 bopd.“With higher oil prices and more visibility on Kurdistan export payments, DNO will ramp up drilling of new development wells at the Tawke license to as many eight this year...

Median overall survival and median progression free survival from the dose-escalation segment of the trial were 10.6 months and 3.9 months, respectivelyTumor burden decrease observed in eight of 15 refractory unresectable mCRC patients, including six of nine patients at the highest dose level of 1×109 cells per infusionEmergence of new T cell clones in the peripheral blood T cell repertoire four months after therapy was observed in patients analyzed from the highest dose level who experienced either a confirmed partial response or stable disease suggesting that modulation of the endogenous immune response may be an important mechanism of action of CYAD‑101 in mCRC patientsPreliminary data from the ongoing expansion cohort of the Phase 1 alloSHRINK expected in the first half of 2021MONT-SAINT-GUIBERT, Belgium, Jan. 18, 2021 (GLOBE...

Amsterdam, January 18, 2021 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announced a global partnership with Irys, a Techstars start-up based in Texas, USA. The new partnership will see Arcadis incorporate Irys’ cutting edge and human centric engagement tools within its own infrastructure, mobility and buildings projects with the aim to increase community involvement, collaboration and improve decision making. Irys, which was founded in 2017, supports government-citizen communication and engagement across major cities and municipalities in the US.  It has pioneered the use of modular-based System as a Service (SaaS) digital platforms and engagement tools – which enable data to be accessed from any device with an internet connection and web browser – to improve...

Due to the pandemic, the Annual General Meeting of Roche Holding Ltd will take place on 16 March 2021 without the physical presence of shareholders and with only the persons required by the Articles of Incorporation in attendanceDuring the Annual General Meeting, shareholders’ rights will be exercised exclusively via the independent proxy, without the physical presence of shareholdersBasel, 18 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that unfortunately it will not be possible for shareholders to attend the Annual General Meeting in person owing to the ongoing pandemic. Our main concern is to protect our shareholders from any potential health risks that may arise because of the ongoing difficult pandemic situation.Attachment18012021_MR_AGM_EN

En raison de la pandémie, l’Assemblée générale ordinaire de Roche Holding SA se tiendra le 16 mars 2021 sans la participation physique des actionnaires uniquement en présence des personnes statutairement nécessairesLes droits des actionnaires lors de l’Assemblée générale seront exclusivement exercés par le représentant indépendant en l’absence physique des actionnairesBâle, le 18 janvier 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) a annoncé aujourd’hui qu’une participation physique des actionnaires à l’Assemblée générale ne serait malheureusement pas possible en raison de la persistance de la pandémie. Etant donné la situation sanitaire toujours préoccupante, notre priorité absolue est de préserver nos actionnaires d’un éventuel risque d’exposition.Pièce jointe18012021_MR_AGM_FR

Die ordentliche Generalversammlung  der Roche Holding AG wird am 16. März 2021 aufgrund der Pandemie ohne physische Anwesenheit der Aktionäre und ausschliesslich mit den statutarisch notwendigen Personen durchgeführtDie Ausübung der Aktionärsrechte bei der Generalversammlung wird ausschliesslich über die unabhängige Stimmrechtsvertreterin erfolgenBasel, 18. Januar 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) gab heute bekannt, dass eine persönliche Teilnahme der Aktionäre an der Generalversammlung aufgrund der anhaltenden Pandemie leider nicht möglich sein wird. Wegen der angespannten Situation ist es unsere oberste Priorität, unsere Aktionäre vor einer möglichen gesundheitlichen Gefährdung zu schützen.Anhang18012021_MR_AGM_DE

Trondheim, 18 January 2021: NORBIT is currently in advanced and exclusive negotiations regarding an add-on acquisition of an undisclosed European company. The acquisition will create a broader platform for growth within the ITS business segment. NORBIT has signed a term sheet to this effect.The target company has, with its strong in-house competence, developed a technology including both hardware and software for vehicle and asset tracking and has several thousand customers, with a substantial share of recurring subscription-based revenues.A preliminary transaction price has been agreed, valuing the target company at an enterprise value of EUR 14.5 million, based on an expected 2020 EBITDA1 of approximately EUR 2 million representing an EBITDA margin2 in excess of 35 per cent.The transaction price and completion of the transaction are...

Trondheim, 18. januar 2021: NORBIT er i fremskredne og eksklusive forhandlinger om oppkjøp av et ikke-navngitt europeisk selskap. Oppkjøpet vil skape en bredere plattform for vekst innen forretnings-segmentet ITS. Partene har signert en intensjonsavtale (term sheet).“Dette oppkjøpet passer godt inn i vår selektive oppkjøpsstrategi. Det gjør oss i stand til å ta en bredere posisjon i markedet for sporing og monitorering av kjøretøy og utstyr. Dette blir en kickstart for å bygge en bredere plattform for videre vekst innenfor ITS-segmentet vårt. Målselskapet har solid erfaring innen dette feltet, en abonnementsbasert forretningsmodell med recurring inntekter og en stor kundebase i sitt hjemmemarked. Vi ser attraktive synergier hvor NORBIT kan bidra både til internasjonalisering og utvidelse av teknologibasen til målselskapet for å løfte...